SPAC

Healthcare

23andMe Gives Up on its Drug Development Dream

Photo by Mike Mozart via CC BY 2.0

A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.

2 min read

Photo by Scott S via CC BY 2.0

Regulation

The SEC Is Finally Cracking Down on SPACs

Regulators voted in new rules aimed at protecting investors considering investing in the nontraditional setup.

1 min read

Photo by Daniel Korpai via Unsplash

Media & Entertainment

Apple Wants in on the News Business, but its News AI Is Alienating Publishers

According to the Financial Times, Apple is ramping up its Apple News division. But can it fix its irritating AI hallucinations?

2 min read
Photo by TechCrunch via CC BY 2.0

Artificial Intelligence

Nvidia, Anthropic Refuel the AI Hype Train

Nvidia, the chipmaking king, has announced a slew of consumer-focused hardware, including a $3,000 “personal AI supercomputer” called Digits.

2 min read
Photo by Ajay Suresh via CC BY 2.0

ETF Upside

FINRA Faces Big Legal Battles in 2025

The Wall Street watchdog is facing criticism from lawmakers, along with two lawsuits, that could theoretically redefine the agency.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.